A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission

Clinical trial NCT05719441 · RECRUITING

Trial details

NCT number: NCT05719441
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute HIV Infection

Start date: 2024-08-19
Primary completion: 2028-04-06
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.